Brian Case
Chief Tech/Sci/R&D Officer chez KORU MEDICAL SYSTEMS, INC.
Fortune : 280 250 $ au 31/03/2024
Profil
Brian Case is currently the Chief Technology Officer at KORU Medical Systems, Inc. Prior to his current position, he served as the Vice President-Research & Development at Fresenius Kabi AG from 2006 to 2022.
Mr. Case holds a graduate degree from Rose-Hulman Institute of Technology, Inc. and an undergraduate degree from the University of Illinois.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/03/2024 | 118 750 ( 0,26% ) | 280 250 $ | 31/03/2024 |
Postes actifs de Brian Case
| Sociétés | Poste | Début |
|---|---|---|
| KORU MEDICAL SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | 18/04/2022 |
Anciens postes connus de Brian Case
| Sociétés | Poste | Fin |
|---|---|---|
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Formation de Brian Case
| Rose-Hulman Institute of Technology, Inc. | Graduate Degree |
| University of Illinois | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KORU MEDICAL SYSTEMS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
